RA: Gore Tex Implants in the Treatment of Atrophic Rhinitis

Sponsor
Hospital Felicio Rocho (Other)
Overall Status
Suspended
CT.gov ID
NCT00832403
Collaborator
(none)
5

Study Details

Study Description

Brief Summary

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: implants of polytetrafluoroethylene in tha nasal fossa

Detailed Description

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Study Design

Study Type:
Observational
Actual Enrollment :
5 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Gore Tex Implants in the Treatment of Atrophic Rhinitis
Study Start Date :
Nov 1, 2006
Actual Primary Completion Date :
Feb 1, 2008

Arms and Interventions

Arm Intervention/Treatment
polytetrafluoroethylene

Other: implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa

Outcome Measures

Primary Outcome Measures

  1. improvement of fetid crusts and atrophy of the mucous bone covering [after surgery recovery]

Secondary Outcome Measures

  1. lack of side effects such as infection [after the treatment]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Symptoms of atrophic rhinitis, with previous clinical treatment without good results
Exclusion Criteria:
  • Patients with mental illness

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Hospital Felicio Rocho

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00832403
Other Study ID Numbers:
  • Rinite Atrófica cep/hfr
First Posted:
Jan 30, 2009
Last Update Posted:
Jan 30, 2009
Last Verified:
Jan 1, 2009
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 30, 2009